Relations beetwen severity of anaemia and certain antiphospholipid antibodies presence in systemic lupus erythematosus patients;Zależności miȩdzy nasileniem niedokrwistości a obecnościa̧ wybranych przeciwciał antyfosfolipidowych u chorych na toczeń rumieniowaty układowy

Polskie Archiwum Medycyny Wewnetrznej

Volumn 115, Issue 5, 2006, Pages 426-431

  Suszek, Dorota ^a   Majdan, Maria ^a,b   Chudzik, Dariusz ^a   Dryglewska, Magdalena ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b Klinika Reumatologii I Uk adowych Chorób Tkanki a cznej AM   (Poland)

Author keywords

Anaemia; Antiphospholipid antibodies; Systemic lupus erythematosus

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; FERRITIN; HEMOGLOBIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY; AUTOANTIBODY;

ANEMIA; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE; FEMALE; HUMAN; MALE; MEAN CORPUSCULAR VOLUME; SYSTEMIC LUPUS ERYTHEMATOSUS; ADULT; AGED; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD; HOSPITALIZATION; IMMUNOLOGY; MIDDLE AGED;

ADULT; AGED; ANEMIA; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES, ANTIPHOSPHOLIPID; AUTOANTIBODIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 33749139506     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Edworthy S.M. Clinical manifestations of SLE. In: Kelley WN, et al, eds. Textbook of rheumatology. 6th ed. Philadelphia: Saunders; 2001. s. 1105.
2. Voulgarelis M., Kokori S., Ioannidis J. i wsp. Anaemia in systemic lupus erythematosus: etiological profile and the role of erythropoietin. Ann Rheum Dis. 2000; 59: 217.
3. Budman D.R., Steinberg A.D. Hematological aspect of systemic lupus erythematosus. Current concepts. Ann Intern Med. 1977; 86: 220.
4. Vlachoyiannopoulos P.G., Karasa F.B., Karakostas K.X, Drosos A.A., Moutsopoulos H.M. Systemic lupus erythematosus in Greece. Clinical features, evolution and outcome: a descriptive analysis of 292 patients. Lupus. 1993; 2: 303.
5. Keeling D.M., Isenberg D.A. Hematological manifestations of systemic lupus erythematosus. Blood Rev. 1993; 7: 199.
6. Giannouli S., Voulgarelis M., Ziakas P.D., Tzioufas A.G. Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment. Ann Rheum Dis. 2006; 65: 144.
7. Weiss G. Pathogenesis and treatment of anaemia of chronic disease. Blood Rev. 2002; 16: 87.
8. Means R.T., Krantz S.B. Progress in understanding the pathogenesis of the anemia of chronic disease: Blood. 1992; 80; 1639.
9. Thomas C., Thomas L. Anaemia of chronic disease: pathophysiology and laboratory diagnosis. Lab Hematol. 2005; 11: 14.
10. Deleze M., Oria C.V., Alarcon-Segovia Occurrence of both hemolytic anemia and thrombocytopenic purpura (Evans syndrome) in systemic lupus erythematosus: relationship to antiphospholipid antibodies. J Rheumatol. 1998; 15: 611.
11. Cervera R., Font J., Lopez-Sato A. i wsp. Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus; prospective analysis of a series of 100 patients. Ann Rheum Dis. 1990; 49: 109.
12. Lang B., Straub R.H., Weber S., Rother E., Fleck M., Peter H.H. Elevated anticardiolipin antibodies in autoimmune hemolytic anaemia irrespective of underlying systemic lupus erythematosus. Lupus. 1997; 6: 652.
13. Miyakis S., Lockshin M.D., Atsumi T. i wsp. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost., 2006; 4: 295.
14. Chen J.L., Li S.L., Xu M., Wang H.B, Ge C.W., Li R.S. Clinical significance of serum transferrin receptor in differential diagnosis of anaemia. Zhonghua Nei Ke Za Zhi, 2004; 43: 423.
15. Means R.T. Hepcidin and anaemia. Blood Rev. 2004; 18: 219.
16. Hanif E., Ayyub M., Anwar M., Ali W., Bashir M. Evaluation of serum transferrin receptor concentration in diagnosing and differentiating iron deficiency anaemia from anaemia of chronic disorders. J Pak Med Assoc. 2005; 55:13.
17. Markovic M., Majkic-Singh N., Subota V. Usefulness of soluble transferrin receptor and ferritin in iron deficiency and chronic disease. Scand J Clin Lab Invest. 2005; 65:, 571.
18. Sthoeger Z., Sthoeger D., Green L., Geltner D. The role of anticardiolipin autoantibodies in the pathogenesis of autoimmune hemolytic anemia in systemic lupus erythematosus. J Rheumatol. 1993; 20: 2058.
19. Cheng H.M. IgG antiphospholipid autoantibody in normal human sera is reactive against bromelain treated human erythrocyte. J Rheumatol. 1993; 20: 400.
20. Bulvik S., Aronson I., Ress S., Jacobs P. Extensive bone marrow necrosis associated with antiphospholipid antibodies. Am J Med. 1995; 98: 572.
21. Paydas S., Koçak R., Zorludemir S., Baslamisli F. Bone marrow necrosis in antiphospholipid syndrome. J Clin Pathol. 1997; 50: 261.
22. Sekigawa I., Ikeda K., Suzuki J. i wsp. Novel clinical manifestations associated with antiphospholipid antibodies: Rheumatology. 2000; 39: 1437.